Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer

Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer

BackgroundMultimodality therapy offers the best opportunity to improve pathological N2 non-small cell lung cancer (NSCLC) prognosis. This paper aimed to evaluate the long-term clinical outcomes and the prognostic factors of upfront surgery as first-line therapy in biopsy-proven clinical N2.MethodsRe...

Full description

Bibliographic Details
Main Authors: Luca Bertolaccini, Elena Prisciandaro, Juliana Guarize, Lara Girelli, Giulia Sedda, Niccolò Filippi, Filippo de Marinis, Lorenzo Spaggiari
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
lung cancer
multimodal treatment
induction chemotherapy
upfront surgery
thoracic surgery
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.933278/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.933278/full

Similar Items